Pricing Log in Create free account

Orchestra BioMed Holdings, Inc. (OBIO) vs ProKidney Corp. (PROK)

Orchestra BioMed Holdings, Inc. and ProKidney Corp. are both Biotechnology companies. Orchestra BioMed Holdings, Inc. and ProKidney Corp. are of similar size ($337.8M and $322.0M). Orchestra BioMed Holdings, Inc. has the higher net margin (−186.3% vs −10,288.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Orchestra BioMed Holdings, Inc. leads on 8 and ProKidney Corp. on 6.

Valuation

Metric OBIO PROK Biotechnology median
P/E n/m n/m 10.60
P/S 11.34 262.28 9.40
P/B 18.76 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 8.99 40.72 9.02
Earnings yield (17.85%) (47.83%) (32.88%)
Free cash flow yield (16.31%) (65.96%) (23.13%)

Profitability

Metric OBIO PROK Biotechnology median
Gross margin 99.51% 100.00% 68.51%
Operating margin (181.36%) (21,664.55%) 0.00%
Net margin (186.30%) (10,288.39%) 0.00%
Free cash flow margin (184.83%) (17,300.61%) 0.00%
Return on equity (607.32%) 8.92% (51.96%)
Return on assets (75.16%) (27.10%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OBIO PROK Biotechnology median
Revenue growth (TTM) 986.14% — 6.76%
EPS growth (last fiscal year) 33.13% 16.13% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OBIO PROK Biotechnology median
Debt to equity 1.80 0.00 0.00
Current ratio 8.26 8.36 4.97
Net debt to EBITDA 1.80 1.70 1.01

Dividend

Metric OBIO PROK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OBIO PROK Biotechnology median
Market cap 337.79m 322.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack